A hydrogel-based stem cell delivery system to treat retinal degenerative diseases

Biomaterials. 2010 Mar;31(9):2555-64. doi: 10.1016/j.biomaterials.2009.12.004. Epub 2010 Jan 6.

Abstract

Regenerative strategies for retinal degenerative diseases are limited by poor cellular survival, distribution and integration after transplantation to the sub-retinal space. To overcome this limitations a stem cell delivery system was developed, taking advantage of the minimally-invasive, injectable and biodegradable properties of a blend of hyaluronan and methylcellulose (HAMC). The physical and biological properties of this unique HAMC formulation were studied. HAMC supported retinal stem-progenitor cell (RSPC) survival and proliferation in vitro. The blend was a viscous solution, exhibiting properties ideal for delivery to the sub-retinal space. In vivo transplantation studies in mice were carried out to investigate both the biodegradability of HAMC in the sub-retinal space over 7 days and the potential of HAMC as a cell delivery vehicle. RSPCs delivered in HAMC were more evenly distributed in the sub-retinal space than those delivered in traditional saline solutions, suggesting that HAMC is a promising vehicle for cellular delivery to the degenerating retina overcoming previously reported barriers to tissue integration in the retina such as cellular aggregation and non-contiguous distribution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials
  • Green Fluorescent Proteins
  • Hyaluronic Acid
  • Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology*
  • Methylcellulose
  • Mice
  • Retinal Degeneration / therapy*
  • Stem Cell Transplantation / methods*
  • Stem Cells / cytology*

Substances

  • Biocompatible Materials
  • Green Fluorescent Proteins
  • Hydrogel, Polyethylene Glycol Dimethacrylate
  • Hyaluronic Acid
  • Methylcellulose